• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧在肿瘤微环境及靶向治疗中的作用

Role of hypoxia in the tumor microenvironment and targeted therapy.

作者信息

Chen Gaoqi, Wu Kaiwen, Li Hao, Xia Demeng, He Tianlin

机构信息

Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.

Department of Gastroenterology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.

出版信息

Front Oncol. 2022 Sep 23;12:961637. doi: 10.3389/fonc.2022.961637. eCollection 2022.

DOI:10.3389/fonc.2022.961637
PMID:36212414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9545774/
Abstract

Tumor microenvironment (TME), which is characterized by hypoxia, widely exists in solid tumors. As a current research hotspot in the TME, hypoxia is expected to become a key element to break through the bottleneck of tumor treatment. More and more research results show that a variety of biological behaviors of tumor cells are affected by many factors in TME which are closely related to hypoxia. In order to inhibiting the immune response in TME, hypoxia plays an important role in tumor cell metabolism and anti-apoptosis. Therefore, exploring the molecular mechanism of hypoxia mediated malignant tumor behavior and therapeutic targets is expected to provide new ideas for anti-tumor therapy. In this review, we discussed the effects of hypoxia on tumor behavior and its interaction with TME from the perspectives of immune cells, cell metabolism, oxidative stress and hypoxia inducible factor (HIF), and listed the therapeutic targets or signal pathways found so far. Finally, we summarize the current therapies targeting hypoxia, such as glycolysis inhibitors, anti-angiogenesis drugs, HIF inhibitors, hypoxia-activated prodrugs, and hyperbaric medicine.

摘要

肿瘤微环境(TME)以缺氧为特征,广泛存在于实体瘤中。作为TME当前的研究热点,缺氧有望成为突破肿瘤治疗瓶颈的关键因素。越来越多的研究结果表明,肿瘤细胞的多种生物学行为受到TME中许多与缺氧密切相关的因素影响。为了抑制TME中的免疫反应,缺氧在肿瘤细胞代谢和抗凋亡中发挥着重要作用。因此,探索缺氧介导恶性肿瘤行为的分子机制和治疗靶点有望为抗肿瘤治疗提供新思路。在这篇综述中,我们从免疫细胞、细胞代谢、氧化应激和缺氧诱导因子(HIF)的角度讨论了缺氧对肿瘤行为的影响及其与TME的相互作用,并列出了目前已发现的治疗靶点或信号通路。最后,我们总结了目前针对缺氧的治疗方法,如糖酵解抑制剂、抗血管生成药物、HIF抑制剂、缺氧激活前药和高压医学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2638/9545774/5493916a16f0/fonc-12-961637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2638/9545774/33a4cf95f607/fonc-12-961637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2638/9545774/5493916a16f0/fonc-12-961637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2638/9545774/33a4cf95f607/fonc-12-961637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2638/9545774/5493916a16f0/fonc-12-961637-g002.jpg

相似文献

1
Role of hypoxia in the tumor microenvironment and targeted therapy.缺氧在肿瘤微环境及靶向治疗中的作用
Front Oncol. 2022 Sep 23;12:961637. doi: 10.3389/fonc.2022.961637. eCollection 2022.
2
Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment.缺氧的病理生理学反应——从疾病的分子机制到药物发现:针对肿瘤微环境的药物发现。
J Pharmacol Sci. 2011;115(4):446-52. doi: 10.1254/jphs.10r25fm. Epub 2011 Mar 16.
3
The regulation of immune checkpoints by the hypoxic tumor microenvironment.缺氧肿瘤微环境对免疫检查点的调控
PeerJ. 2021 May 7;9:e11306. doi: 10.7717/peerj.11306. eCollection 2021.
4
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.血管内皮生长因子在低氧和免疫抑制性肿瘤微环境中的作用:治疗意义的展望。
Med Oncol. 2019 Nov 11;37(1):2. doi: 10.1007/s12032-019-1329-2.
5
Hypoxia signaling in cancer: Implications for therapeutic interventions.癌症中的缺氧信号传导:对治疗干预的意义。
MedComm (2020). 2023 Jan 23;4(1):e203. doi: 10.1002/mco2.203. eCollection 2023 Feb.
6
Fatal Alliance of Hypoxia-/HIF-1α-Driven Microenvironmental Traits Promoting Cancer Progression.缺氧/HIF-1α 驱动的微环境特征的致命联盟促进癌症进展。
Adv Exp Med Biol. 2020;1232:169-176. doi: 10.1007/978-3-030-34461-0_21.
7
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.肿瘤微环境和上皮间质转化作为克服肿瘤多药耐药的靶点。
Drug Resist Updat. 2020 Dec;53:100715. doi: 10.1016/j.drup.2020.100715. Epub 2020 Jun 20.
8
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies.肿瘤缺氧揭秘:对微环境、检测工具和新兴疗法的深入了解。
Clin Exp Med. 2024 Oct 3;24(1):235. doi: 10.1007/s10238-024-01501-1.
9
Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets.引导缺氧肿瘤微环境和缺氧诱导因子以阐明癌症免疫疗法在药物靶点方面的现有前景与挑战。
Curr Drug Targets. 2022;23(5):471-485. doi: 10.2174/1389450123666220111114649.
10
Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.实体瘤生理学与缺氧诱导的化学/放射抗性:癌症治疗的新策略:一氧化氮供体作为治疗增强剂
Nitric Oxide. 2008 Sep;19(2):205-16. doi: 10.1016/j.niox.2008.04.026. Epub 2008 May 6.

引用本文的文献

1
Linking tumour angiogenesis and tumour immunity.将肿瘤血管生成与肿瘤免疫联系起来。
Nat Rev Immunol. 2025 Aug 14. doi: 10.1038/s41577-025-01211-z.
2
Metabolic Interactions in the Tumor Microenvironment of Classical Hodgkin Lymphoma: Implications for Targeted Therapy.经典型霍奇金淋巴瘤肿瘤微环境中的代谢相互作用:对靶向治疗的启示
Int J Mol Sci. 2025 Aug 4;26(15):7508. doi: 10.3390/ijms26157508.
3
Combination of Irreversible Electroporation and -NT Bacterial Therapy for Colorectal Liver Metastasis.不可逆电穿孔与-NT细菌疗法联合治疗结直肠癌肝转移

本文引用的文献

1
Generation, secretion and degradation of cancer immunotherapy target PD-L1.癌症免疫治疗靶点 PD-L1 的产生、分泌和降解。
Cell Mol Life Sci. 2022 Jul 11;79(8):413. doi: 10.1007/s00018-022-04431-x.
2
A vaccine targeting resistant tumours by dual T cell plus NK cell attack.一种通过双重 T 细胞加自然杀伤细胞攻击来靶向耐药肿瘤的疫苗。
Nature. 2022 Jun;606(7916):992-998. doi: 10.1038/s41586-022-04772-4. Epub 2022 May 25.
3
Emerging Trends and Research Foci in Tumor Microenvironment of Pancreatic Cancer: A Bibliometric and Visualized Study.
Cancers (Basel). 2025 Jul 26;17(15):2477. doi: 10.3390/cancers17152477.
4
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.深入了解与三级淋巴结构相关的肿瘤浸润性基质细胞及其在癌症免疫治疗中的潜在功能。
Exp Hematol Oncol. 2025 Aug 10;14(1):105. doi: 10.1186/s40164-025-00695-8.
5
Histone lactylation: a new target for overcoming immune evasion and therapy resistance.组蛋白乳酰化:克服免疫逃逸和治疗抗性的新靶点。
Med Oncol. 2025 Aug 2;42(9):399. doi: 10.1007/s12032-025-02940-w.
6
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies.线粒体自噬对癌症和神经退行性疾病的影响:对未来治疗的启示
J Hematol Oncol. 2025 Aug 1;18(1):78. doi: 10.1186/s13045-025-01727-w.
7
Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance.解析河马通路:YAP/TAZ在癌症转移和耐药性中扮演核心角色。
EXCLI J. 2025 Jun 6;24:612-637. doi: 10.17179/excli2025-8351. eCollection 2025.
8
The Overlapping Biology of Sepsis and Cancer and Therapeutic Implications.脓毒症与癌症的重叠生物学特性及其治疗意义
Biomedicines. 2025 May 23;13(6):1280. doi: 10.3390/biomedicines13061280.
9
FOLR1-Targeted Oxygen-Delivering Nanosomes Enhance Chemo-Induced Apoptosis in Hypoxic Cancer.靶向叶酸受体1的携氧纳米粒增强缺氧癌细胞化疗诱导的凋亡
Int J Nanomedicine. 2025 May 28;20:6875-6889. doi: 10.2147/IJN.S513688. eCollection 2025.
10
Inflammation, Immunosuppression, and Immunotherapy in Pancreatic Cancer-Where Are We Now?胰腺癌中的炎症、免疫抑制与免疫治疗——我们目前的进展如何?
Cancers (Basel). 2025 Apr 28;17(9):1484. doi: 10.3390/cancers17091484.
胰腺癌肿瘤微环境的新兴趋势与研究热点:一项文献计量学与可视化研究
Front Oncol. 2022 Apr 19;12:810774. doi: 10.3389/fonc.2022.810774. eCollection 2022.
4
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.USP25 促进病理性 HIF-1 驱动的代谢重编程,是胰腺癌的一个潜在治疗靶点。
Nat Commun. 2022 Apr 19;13(1):2070. doi: 10.1038/s41467-022-29684-9.
5
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer.癌症治疗中克服耐药性以获得更好疗效的创新方法的最新进展。
J Control Release. 2022 Jun;346:43-70. doi: 10.1016/j.jconrel.2022.04.007. Epub 2022 Apr 8.
6
Role of endoplasmic reticulum stress in apoptosis induced by HK2 inhibitor and its potential as a new drug combination strategy.内质网应激在 HK2 抑制剂诱导细胞凋亡中的作用及其作为一种新的药物联合策略的潜力。
Cell Stress Chaperones. 2022 May;27(3):273-283. doi: 10.1007/s12192-022-01267-z. Epub 2022 Mar 30.
7
A Metabolic Multistage Glutathione Depletion Used for Tumor-Specific Chemodynamic Therapy.一种用于肿瘤特异性化学动力疗法的代谢多阶段谷胱甘肽耗竭法
ACS Nano. 2022 Mar 22;16(3):4228-4238. doi: 10.1021/acsnano.1c10231. Epub 2022 Feb 25.
8
Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling.基于主体模型的缺氧激活前药CP-506的组织药代动力学特性及旁观者效应潜力
Front Pharmacol. 2022 Feb 8;13:803602. doi: 10.3389/fphar.2022.803602. eCollection 2022.
9
IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity.IL-9/STAT3/脂肪酸氧化介导的脂质过氧化作用导致 Tc9 细胞寿命延长和增强的抗肿瘤活性。
J Clin Invest. 2022 Apr 1;132(7). doi: 10.1172/JCI153247.
10
HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer.缺氧诱导因子-1α 抑制促进免疫检查点阻断在非小细胞肺癌治疗中的疗效。
Cancer Lett. 2022 Apr 10;531:39-56. doi: 10.1016/j.canlet.2022.01.027. Epub 2022 Jan 26.